Quetiapine Fumarate

CHEMBL3188993 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
883.1 g/mol
LogP
Phase
4

A salt formulation of quetiapine used to treat bipolar disorder and schizophrenia by balancing chemical signals in the brain. It helps reduce episodes of mania, depression, and psychotic symptoms.

分子量

883.1000 g/mol

TPSA

222.00 Ų

治療領域

作用機序

Atypical antipsychotic; antagonist at multiple receptors.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Atypical antipsychotic; antagonist at multiple receptors.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1

InChI

InChI=1S/2C21H25N3O2S.C4H4O4/c2*25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21;5-3(6)1-2-4(7)8/h2*1-8,25H,9-16H2;1-2H,(H,5,6)(H,7,8)/b;;2-1+

Molecular Formula

C46H54N6O8S2

HBD / HBA

4 / 14

回転可能結合数

14

重原子数

62

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A salt formulation of quetiapine used to treat bipolar disorder and schizophrenia by balancing chemical signals in the brain. It helps reduce episodes of mania, depression, and psychotic symptoms.

Atypical antipsychotic; antagonist at multiple receptors.

Yes, Quetiapine Fumarate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3188993. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5281025. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.